Ankur Shah, DO
Clinical Cardiac Electrophysiology · Columbus, OHNPI 1013332857
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (39.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Medtronic at 51.1% of the total. Reporting peaked in 2020 at $20,050 and has fallen 57.8% since, to $8,459 in 2025.
Across 420 payments — averaging $178.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$38K
- Boston Scientific$18K
- Abbott$13K
- Biosense Webster, Inc.$3K
- Biotronik Inc.$465
- AstraZeneca$323
- plus $2K from 18 others
What the payments were for
- Speaking & faculty fees$3,1254%
- Grants$29,39339%
- Travel & lodging$22,26530%
- Food & beverage$19,30126%
- Education$7191%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 130 | $38,225 |
| Boston Scientific | 135 | $17,994 |
| Abbott | 79 | $12,733 |
| Biosense Webster, Inc. | 29 | $3,151 |
| Biotronik Inc. | 2 | $465 |
| AstraZeneca | 7 | $323 |
| Amgen | 11 | $313 |
| Medical Device Business Services, Inc. | 2 | $185 |
| Edwards Lifesciences | 1 | $176 |
| Kestra Medical Technology Services, Inc. | 2 | $159 |
| Johnson & Johnson | 3 | $140 |
| Amarin Pharma, Inc. | 1 | $125 |
| Angiodynamics, Inc. | 1 | $121 |
| Pfizer | 1 | $120 |
| Portola Pharmaceuticals, LLC | 1 | $114 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $102 |
| E.r. Squibb & Sons, L.L.C. | 1 | $94 |
| Atricure, Inc. | 2 | $69 |
| Lantheus Medical Imaging, Inc. | 1 | $67 |
| Philips North America LLC | 3 | $53 |
| Novartis | 2 | $25 |
| Actelion Pharmaceuticals US, Inc. | 2 | $20 |
| Genentech USA, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$3,088
- Carto 3$2,507
- GENERAL - THERAPIES$2,454
- THERAPIES$2,311
- Micra$1,831
- Farapulse$1,424
- ENSITE$1,217
- WATCHMAN Access System$978
- WATCHMAN FLX$850
- EMBLEM MRI S-ICD$698
- GENERAL - STRUCTURAL HEART$661
- ENSITE PRECISION$533
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$497
- Ensite Cardiac Mapping System$438
- EVERA MRI XT DR SURESCAN$386
- EnSite Precision Cardiac Mapping System$331
- AURORA EV-ICD MRI SURESCAN$303
- SelectSecure$244
- AMPLATZER AMULET$207
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$176
How this compares
$74,803 in reported general payments places this provider in the 85th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
See all clinical cardiac electrophysiology providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 210 | $229,627 |
| XareltoRivaroxaban | 185 | $197,012 |
| Flecainide Acetate | 225 | $7,745 |
| Dofetilide | 26 | $7,086 |
| Metoprolol Succinate | 261 | $2,975 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 54 | $2,254 |
| Propafenone Hcl ErPropafenone Hcl | 13 | $1,765 |
| Amiodarone Hcl | 88 | $1,076 |
| SotalolSotalol Hcl | 27 | $753 |
| Pantoprazole Sodium | 48 | $311 |
| Warfarin Sodium | 48 | $307 |
| Metoprolol Tartrate | 53 | $302 |
| Atorvastatin Calcium | 15 | $177 |
| Losartan Potassium | 15 | $130 |
| Carvedilol | 19 | $99 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $120 | $229,627210 claims |
| Johnson & JohnsonXarelto | $140 | $197,012185 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
Other clinical cardiac electrophysiology in Columbus
- Anish AminColumbus$1.1M
- John HummelColumbus$275K
- Auroa BadinColumbus$188K
- Ralph AugostiniColumbus$174K
- David NemerColumbus$97K
- Eugene FuColumbus$96K
- Sampath GundaColumbus$73K
- Sreedhar BillakantyColumbus$64K
- Salvatore SavonaColumbus$49K
- Natee SirinvaravongColumbus$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.